194 related articles for article (PubMed ID: 32362500)
1. Dietary Patterns and Risk of Invasive Ductal and Lobular Breast Carcinomas: A Systematic Review and Meta-analysis.
Dianatinasab M; Rezaian M; HaghighatNezad E; Bagheri-Hosseinabadi Z; Amanat S; Rezaeian S; Masoudi A; Ghiasvand R
Clin Breast Cancer; 2020 Aug; 20(4):e516-e528. PubMed ID: 32362500
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity in risk factors for ductal and lobular breast carcinomas: A case-control study.
Dianatinasab M; Fararouei M; Daneshi N; Rezaian S; Mohammadianpanah M; Chaman R; Ghiasvand R
Int J Cancer; 2019 Dec; 145(11):2917-2925. PubMed ID: 30719718
[TBL] [Abstract][Full Text] [Related]
3. Adherence to a western dietary pattern and risk of invasive ductal and lobular breast carcinomas: a case-control study.
Foroozani E; Akbari A; Amanat S; Rashidi N; Bastam D; Ataee S; Sharifnia G; Faraouei M; Dianatinasab M; Safdari H
Sci Rep; 2022 Apr; 12(1):5859. PubMed ID: 35393463
[TBL] [Abstract][Full Text] [Related]
4. Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma.
Adachi Y; Ishiguro J; Kotani H; Hisada T; Ichikawa M; Gondo N; Yoshimura A; Kondo N; Hattori M; Sawaki M; Fujita T; Kikumori T; Yatabe Y; Kodera Y; Iwata H
BMC Cancer; 2016 Mar; 16():248. PubMed ID: 27015895
[TBL] [Abstract][Full Text] [Related]
5. The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast.
Zhao H
Breast Cancer; 2021 Jan; 28(1):187-195. PubMed ID: 32812198
[TBL] [Abstract][Full Text] [Related]
6. Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade.
Metzger-Filho O; Ferreira AR; Jeselsohn R; Barry WT; Dillon DA; Brock JE; Vaz-Luis I; Hughes ME; Winer EP; Lin NU
Oncologist; 2019 Jul; 24(7):e441-e449. PubMed ID: 30518616
[TBL] [Abstract][Full Text] [Related]
7. Is there an association between invasive lobular carcinoma of the breast and a family history of gastric cancer?
Chikman B; Davidson T; Kais H; Jeroukhimov I; Leshno A; Sandbank J; Halevy A; Lavy R
Fam Cancer; 2016 Jan; 15(1):41-7. PubMed ID: 26358115
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Treatment Outcome Between Invasive Lobular and Ductal Carcinomas in Patients Receiving Partial Breast Irradiation With Intraoperative Electrons.
Leonardi MC; Maisonneuve P; Mastropasqua MG; Cattani F; Fanetti G; Morra A; Lazzari R; Bazzani F; Caputo M; Rotmensz N; Gerardi MA; Ricotti R; Enrica Galimberti V; Veronesi P; Dicuonzo S; Viale G; Jereczek-Fossa BA; Orecchia R
Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):173-181. PubMed ID: 28816144
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Single-Agent Chemotherapy for Patients with Advanced Invasive Lobular Carcinoma: A Pooled Analysis from Three Clinical Trials.
Pérez-Garcia J; Cortés J; Metzger Filho O
Oncologist; 2019 Aug; 24(8):1041-1047. PubMed ID: 30578311
[TBL] [Abstract][Full Text] [Related]
10. Patients with invasive lobular breast cancer are less likely to undergo breast-conserving surgery: a population based study in the Netherlands.
Truin W; Roumen RM; Siesling S; van der Heiden-van der Loo M; Duijm LE; Tjan-Heijnen VC; Voogd AC
Ann Surg Oncol; 2015 May; 22(5):1471-8. PubMed ID: 25323475
[TBL] [Abstract][Full Text] [Related]
11. Contralateral breast cancer: incidence according to ductal or lobular phenotype of the primary.
Langlands F; White J; Kearins O; Cheung S; Burns R; Horgan K; Sharma N; Dodwell D
Clin Radiol; 2016 Feb; 71(2):159-63. PubMed ID: 26703116
[TBL] [Abstract][Full Text] [Related]
12. Reproductive and anthropometric factors in relation to the risk of lobular and ductal breast carcinoma among women 65-79 years of age.
Li CI; Malone KE; Porter PL; Weiss NS; Tang MT; Daling JR
Int J Cancer; 2003 Nov; 107(4):647-51. PubMed ID: 14520705
[TBL] [Abstract][Full Text] [Related]
13. Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis.
Turashvili G; Bouchal J; Baumforth K; Wei W; Dziechciarkova M; Ehrmann J; Klein J; Fridman E; Skarda J; Srovnal J; Hajduch M; Murray P; Kolar Z
BMC Cancer; 2007 Mar; 7():55. PubMed ID: 17389037
[TBL] [Abstract][Full Text] [Related]
14. Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials.
Pestalozzi BC; Zahrieh D; Mallon E; Gusterson BA; Price KN; Gelber RD; Holmberg SB; Lindtner J; Snyder R; Thürlimann B; Murray E; Viale G; Castiglione-Gertsch M; Coates AS; Goldhirsch A;
J Clin Oncol; 2008 Jun; 26(18):3006-14. PubMed ID: 18458044
[TBL] [Abstract][Full Text] [Related]
15. Relative effectiveness of adjuvant chemotherapy for invasive lobular compared with invasive ductal carcinoma of the breast.
Marmor S; Hui JYC; Huang JL; Kizy S; Beckwith H; Blaes AH; Rueth NM; Tuttle TM
Cancer; 2017 Aug; 123(16):3015-3021. PubMed ID: 28382636
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the clinicopathological features of invasive ductal, invasive lobular, and mixed (invasive ductal + invasive lobular) carcinoma of the breast.
Zengel B; Yararbas U; Duran A; Uslu A; Elıyatkın N; Demırkıran MA; Cengiz F; Şimşek C; Postacı H; Vardar E; Durusoy R
Breast Cancer; 2015 Jul; 22(4):374-81. PubMed ID: 23925582
[TBL] [Abstract][Full Text] [Related]
17. Long-term statin use and risk of ductal and lobular breast cancer among women 55 to 74 years of age.
McDougall JA; Malone KE; Daling JR; Cushing-Haugen KL; Porter PL; Li CI
Cancer Epidemiol Biomarkers Prev; 2013 Sep; 22(9):1529-37. PubMed ID: 23833125
[TBL] [Abstract][Full Text] [Related]
18. The changing incidence of in situ and invasive ductal and lobular breast carcinomas: United States, 1999-2004.
Eheman CR; Shaw KM; Ryerson AB; Miller JW; Ajani UA; White MC
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1763-9. PubMed ID: 19454615
[TBL] [Abstract][Full Text] [Related]
19. Survival patterns of invasive lobular and invasive ductal breast cancer in a large population-based cohort with two decades of follow up.
Chamalidou C; Fohlin H; Albertsson P; Arnesson LG; Einbeigi Z; Holmberg E; Nordenskjöld A; Nordenskjöld B; Karlsson P; Linderholm B;
Breast; 2021 Oct; 59():294-300. PubMed ID: 34388695
[TBL] [Abstract][Full Text] [Related]
20. Differences in sensitivity to neoadjuvant chemotherapy among invasive lobular and ductal carcinoma of the breast and implications on surgery-A systematic review and meta-analysis.
O'Connor DJ; Davey MG; Barkley LR; Kerin MJ
Breast; 2022 Feb; 61():1-10. PubMed ID: 34864494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
